Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative

Abstract Introduction Analyses of off‐label use of acetylcholinesterase inhibitors (AChEIs) in mild cognitive impairment (MCI) has produced mixed results. Post hoc analyses of observational cohorts, such as the Alzheimer's Disease Neuroimaging Initiative (ADNI), have reported deleterious effects in...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Eddie Stage, Diana Svaldi, Sophie Sokolow, Shannon L. Risacher, Krisztina Marosi, Jerome I. Rotter, Andrew J. Saykin, Liana G. Apostolova, for the Alzheimer's Disease Neuroimaging Initiative
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Wiley 2021-01-01
سلاسل:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
الموضوعات:	acetylcholinesterase inhibitor Alzheimer's Disease Neuroimaging Initiative fluorodeoxyglucose longitudinal magnetic resonance imaging mild cognitive impairment
الوصول للمادة أونلاين:	https://doi.org/10.1002/trc2.12168
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!